These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1372956)

  • 1. C1-inhibitor prevents PEG fractionation-induced, EDTA-resistant activation of mouse complement.
    van den Berg CW; Aerts PC; van Dijk H
    Mol Immunol; 1992 Mar; 29(3):363-9. PubMed ID: 1372956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.
    van den Berg CW; Démant P; Aerts PC; Van Dijk H
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10711-5. PubMed ID: 1438267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved method for measuring C1-r-C1-s-(C1 inh)2 complexes by an enzyme-linked immunosorbent assay.
    Mathews KP; Herschbach JH; Chambers SL; Zuraw BL
    J Clin Lab Anal; 1995; 9(3):196-203. PubMed ID: 7602428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.
    Prandini MH; Reboul A; Colomb MG
    Biochem J; 1986 Jul; 237(1):93-8. PubMed ID: 3099750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of C1 inhibitor. A new approach for the isolation of this biologically important plasma protease inhibitor.
    Prograis LJ; Hammer CH; Katusha K; Frank MM
    J Immunol Methods; 1987 May; 99(1):113-22. PubMed ID: 3553333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid, activity-guided isolation of sex-limited protein (Slp) from mouse serum by fractionated precipitation and high-performance liquid chromatography.
    Van den Berg CW; Van Dijk H
    J Immunol Methods; 1994 Mar; 169(2):251-6. PubMed ID: 8133084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.
    Bos IG; van Mierlo GJ; Bleeker WK; Rigter GM; te Velthuis H; Dickneite G; Hack CE
    Int Immunopharmacol; 2001 Aug; 1(8):1583-95. PubMed ID: 11515821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold-dependent activation of complement: recognition, assessment, and mechanism.
    Mathews KP; Mentyka RA; Chambers SL; Hugli TE; Herschbach JH; Zuraw BL
    J Clin Immunol; 1992 Sep; 12(5):362-70. PubMed ID: 1430107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A postulated mechanism for heparin's potentiation of C1 inhibitor function.
    Caughman GB; Boackle RJ; Vesely J
    Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
    Mikami A; Kohno M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography.
    Dubin A; Potempa J; Travis J
    Prep Biochem; 1990; 20(1):63-74. PubMed ID: 1694995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of a proteinase inhibitor from bovine serum with C1-inhibitor activity.
    Van Nostrand WE; Cunningham DD
    Biochim Biophys Acta; 1987 Feb; 923(2):167-75. PubMed ID: 3814612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.
    Weiss V; Engel J
    Hoppe Seylers Z Physiol Chem; 1983 Mar; 364(3):295-301. PubMed ID: 6602754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
    Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
    Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.